BY INVITATION ONLY | QUALIFIED INVESTORS ONLY
TOWER GENERATIONS PROGRAM
PRIVATE ACCESS TO THE WORLD LEADING GENERATIONAL HEALTH INNOVATORS
TOWER VERIFIED
TOWER offers private sessions focused on groundbreaking innovators reshaping generational health in the United States and beyond.
Introductions to CEOs of curated edge-case Generational Health companies create access to leaders t the frontier of Bio AI, longevity, regenerative medicine, women’s health, and human health systems.
Confidential company updates will be made through journalist-moderated conversations, designed to simplify complexity and support direct, investment-ready decision-making.
Participation is intentionally limited to a select group of qualified investors and family offices.
Life sciences is one of the most consequential sectors in venture — and one of the most misunderstood. The deal flow is there, the innovation is extraordinary, but for most investors outside of specialized institutional funds, it's been hard to access and harder to evaluate.
That's exactly the kind of barrier Uncharted:Pitches X TOWER is built to break down — together.
Tower and Uncharted Pitches have teamed up to share the latest innovation in life sciences with access to empathetic capital, ready to deploy. .
INNOVATOR SPOTLIGHT
Quirs.AI is Bio-AI clinical prediction platform combining AI with “patient-on-a-chip” technology to predict treatment outcomes, and forms the basis of a new genomic data center and precision longevity--Already scaling a 400M program with country soveriegn.
Stealth Dementia Prevention Co. is Leading IP in biotechnology, creating the first Dementia prevention platform, initial product proven to prevent severe dementia by up to 50%--with backlog of interested patients and providers at premium off label pricing.
Vitality IP is an AI-powered precision nutrition platform integrating biological data, food science, and retail fulfillment to scale longevity interventions-- With over 5 major contracts and revenue positive to date.
Domestic Futures: Choice is not ours. The most consequential decisions of our lives are made without clear information. Family formation guidance is filtered by financial interest, political agenda, and platform design. What reaches young people arrives algorithmically: personalized, optimized, and invisible in its bias and inaccuracy. The choices of one generation become the inherited reality of the next.
Nanost is building a low-cost, heat-stable point-of-care diagnostics platform that combines multiplex biomarker testing with an AI-enabled data layer to enable rapid, decentralized healthcare delivery across emergency care, military medicine, rural settings, and clinical research.
Anecare is the leading the globe in surgically safer anesthesia. Anecare is transforming anesthesia recovery with a clinically proven, FDA‑cleared technology that protects brain health – especially in children and seniors – accelerates recovery, and reduces the environmental and occupational impact of inhaled anesthetics, delivering measurable value for hospitals, payers, and patients.
HekaBio scales healthcare commercialization across boarders: A platform licensing and scaling innovative pharma, diagnostics, and MedTech assets across Japan and APAC markets. Already 8 assets in progress and clear measurable revenues.
INNOVATOR DETAIL
Leading the globe in Bio AI: Most people still don’t understand Bio AI. They should.
Bio AI is changing the paradigm of medicine, from how therapeutics are discovered and developed, to how they reach patients faster and more equitably.
Quirs.AI is Bio-AI clinical prediction platform combining AI with “patient-on-a-chip” technology to predict treatment outcomes, and forms the basis of a new genomic data center and precision longevity--Already scaling a 400M program with country soveriegn.
Leading the globe in dementia prevention: Stealth Mode
Stealth Dementia Prevention Co. is Leading IP in biotechnology, creating the first Dementia prevention platform, initial product proven to prevent severe dementia by up to 50%--with backlog of interested patients and providers at premium off label pricing
Leading the globe in precision nutrition.
Vitality IP is an AI-powered precision nutrition platform integrating biological data, food science, and retail fulfillment to scale longevity interventions-- WIth over 5 major contracts and revenue positive to date.
Domestic Futures:
The most consequential decisions of our lives are made without real information, because the information
itself is compromised. Reproductive health guidance is filtered by financial interest, political agenda, and
platform design. What reaches young people arrives algorithmically: personalized, optimized, and invisible
in its bias and inaccuracy. The choices of one generation become the inherited reality of the next.
Nanost is building a low-cost, heat-stable point-of-care diagnostics platform that combines multiplex biomarker testing with an AI-enabled data layer to enable rapid, decentralized healthcare delivery across emergency care, military medicine, rural settings, and clinical research.
Anecare is a medical device innovator that is transforming anesthesia care with ANEclear, a clinically proven, FDAcleared technology that protects brain health – especially in children and seniors – to accelerate recovery and reduce the environmental and occupational impact of inhaled anesthetics.
HekaBio scales healthcare commercialization across boardders: A platform licensing and scaling innovative pharma, diagnostics, and MedTech assets across Japan and APAC markets.
Nanost is building a low-cost, heat-stable point-of-care diagnostics platform that combines multiplex biomarker testing with an AI-enabled data layer to enable rapid, decentralized healthcare delivery across emergency care, military medicine, rural settings, and clinical research.
QUALIFIED INVESTORS ONLY
THIS INVITATION IS NON-TRANSFERABLE
BY INVITE ONLY: ONLINE REGISTRATION
Copyright 2026. Tower Capital Group LLC. All Rights Reserved
Important Disclosures and Disclaimers
This document is for informational purposes only and is intended exclusively for the use of the persons to whom it is delivered and the information provided therein is confidential and may not be reproduced in its entirety or in part, or redistributed to any party in any form, without the prior written consent of TOWER Capital Group, LLC, or any named affiliate entity (“TOWER” or “TOWER Capital”). Information contained in this document is current only as of the date specified in the document, regardless of the time of delivery or of any investment, and TOWER does not undertake any duty to update the information set forth herein.
Certain information included in this document is based upon information reasonably available to TOWER. Furthermore, the information included in this document has been obtained from sources TOWER believes to be reliable; however, these sources cannot be guaranteed as to their accuracy or completeness No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information contained in this document and no liability is accepted for the accuracy or completeness of any such information. TOWER maintains historical materials and disclosures in this document for archival and regulatory purposes. The information contained in such materials and disclosures is believed to be reliable at the time it is initially presented, and TOWER assumes no responsibility for updating information to reflect subsequent developments. Any transactions highlighted within investment updates in this material are not representative of the entire investment portfolio and there is no guarantee that other investments or transactions in the portfolio not described herein are/will be successful. For additional important disclosures and notices, please review our Notices page at www.towercapital.org/notices.